Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
Adv Microb Physiol ; 84: 135-241, 2024.
Article in English | MEDLINE | ID: mdl-38821632

ABSTRACT

Ninety-five years after Fleming's discovery of penicillin, a bounty of antibiotic compounds have been discovered, modified, or synthesised. Diversification of target sites, improved stability and altered activity spectra have enabled continued antibiotic efficacy, but overwhelming reliance and misuse has fuelled the global spread of antimicrobial resistance (AMR). An estimated 1.27 million deaths were attributable to antibiotic resistant bacteria in 2019, representing a major threat to modern medicine. Although antibiotics remain at the heart of strategies for treatment and control of bacterial diseases, the threat of AMR has reached catastrophic proportions urgently calling for fresh innovation. The last decade has been peppered with ground-breaking developments in genome sequencing, high throughput screening technologies and machine learning. These advances have opened new doors for bioprospecting for novel antimicrobials. They have also enabled more thorough exploration of complex and polymicrobial infections and interactions with the healthy microbiome. Using models of infection that more closely resemble the infection state in vivo, we are now beginning to measure the impacts of antimicrobial therapy on host/microbiota/pathogen interactions. However new approaches are needed for developing and standardising appropriate methods to measure efficacy of novel antimicrobial combinations in these contexts. A battery of promising new antimicrobials is now in various stages of development including co-administered inhibitors, phages, nanoparticles, immunotherapy, anti-biofilm and anti-virulence agents. These novel therapeutics need multidisciplinary collaboration and new ways of thinking to bring them into large scale clinical use.


Subject(s)
Anti-Bacterial Agents , Bacterial Infections , Humans , Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacteria/drug effects , Bacteria/genetics , Drug Resistance, Bacterial , Animals , Host-Pathogen Interactions
2.
J Vis Exp ; (203)2024 Jan 05.
Article in English | MEDLINE | ID: mdl-38251745

ABSTRACT

Temperate phages are found integrated as prophages in the majority of bacterial genomes. Some prophages are cryptic and fixed in the bacterial chromosome, but others are active and can be triggered into a replicative form either spontaneously or by exposure to inducing factors. Prophages are commonly associated with the ability to confer toxin production or other virulence-associated traits on their host cell. More recent studies have shown they can play a much bigger role in altering the physiology of their hosts. The technique described here has enabled us to investigate how prophages affect gene expression in the opportunistic bacterium Pseudomonas aeruginosa. In this work, the growth of the wild-type P. aeruginosa strain PAO1 was compared with that of isogenic lysogens carrying different combinations of prophages from the Liverpool Epidemic Strain (LES) LESB58. In a lysogen culture, a proportion of bacterial cells will be supporting lytic bacteriophage replication (spontaneous induction) with a high level of expression per cell of late phage genes, such as those associated with the assembly of phage particles, thus masking the low-level gene expression associated with lysogen-restricted gene expression. The impact of spontaneous induction can thus obscure prophage gene expression across a lysogen population. Growth profiling experiments were used to identify spontaneous induction, which was minimal during the early exponential growth phase. This study reports how to prepare sample cultures during the early exponential growth phase and how to set up adequate controls despite low cell numbers. These protocols ensure the reliable and reproducible comparison of wild-type and lysogenic bacteria under various conditions, thus improving the transcriptomic profiling of prophage genomes and aiding in the identification of previously unrecognized prophage functions.


Subject(s)
Bacteriophages , Bacteriophages/genetics , Gene Expression Profiling , Bacterial Typing Techniques , Cell Count , Chromosomes, Bacterial
3.
Microbiology (Reading) ; 167(5)2021 05.
Article in English | MEDLINE | ID: mdl-34032566

ABSTRACT

Tackling antimicrobial resistance (AMR) is particularly challenging in low-resource settings such as Fort Portal Regional Referral Hospital (FPRRH) in Western Uganda. Specific knowledge of local AMR epidemiology is required to inform evidence-based improvement of antibiotic stewardship measures in the hospital. To address this, we combined existing antimicrobial susceptibility testing (AST) from FPRRH, with whole genome sequencing (WGS) of 41 Staphylococcus aureus isolates (2017-2019). AST revealed 73 % (30 of 41) of isolates were resistant to one or more antibiotics and 29 % (12 of 41) were multi-drug resistant (MDR). Resistance phenotypes were largely explained by the presence of antibiotic resistance genes in WGS data. Five isolates were methicillin-resistant S. aureus (MRSA) and MDR. Although all isolates were susceptible to clindamycin, a 24 % carriage of erm genes suggests potential for rapid development of resistance. We inferred a population structure for the S. aureus isolates by comparing their core genomes. Twenty isolates formed a tight cluster corresponding to multilocus sequence typing clonal complex (CC) 152, a CC found to be particularly prevalent in northern Africa. The frequency of genes associated with methicillin, chloramphenicol and ciprofloxacin resistance were significantly lower among CC152 strains than non-CC152 strains; thus, in keeping with previous work, we find that CC152 is almost exclusively methicillin-sensitive S. aureus (MSSA). Also, in agreement with other studies, we observed that the occurrence of Panton-Valentine leukocidin toxin-encoding genes was significantly higher among CC152 strains than non-CC152 strains. However, we also observed that the coagulase gene was over-represented in this CC, further defining the virulence strategy of this important pathogen. By generating detailed information about the epidemiology of circulating S. aureus and their antibiotic susceptibility, our study has provided, for the first time, data on which evidence-based infection and AMR interventions at FPRRH can be based.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Genome, Bacterial , Humans , Microbial Sensitivity Tests , Middle Aged , Referral and Consultation/statistics & numerical data , Staphylococcal Infections/drug therapy , Staphylococcus aureus/genetics , Staphylococcus aureus/metabolism , Uganda , Virulence Factors/genetics , Virulence Factors/metabolism
4.
J Med Microbiol ; 67(2): 148-159, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29297851

ABSTRACT

PURPOSE: Several genetic regulators belonging to AraC family are involved in the emergence of MDR isolates of E. aerogenes due to alterations in membrane permeability. Compared with the genetic regulator Mar, RamA may be more relevant towards the emergence of antibiotic resistance. METHODOLOGY: Focusing on the global regulators, Mar and Ram, we compared the amino acid sequences of the Ram repressor in 59 clinical isolates and laboratory strains of E. aerogenes. Sequence types were associated with their corresponding multi-drug resistance phenotypes and membrane protein expression profiles using MIC and immunoblot assays. Quantitative gene expression analysis of the different regulators and their targets (porins and efflux pump components) were performed. RESULTS: In the majority of the MDR isolates tested, ramR and a region upstream of ramA were mutated but marR or marA were unchanged. Expression and cloning experiments highlighted the involvement of the ram locus in the modification of membrane permeability. Overexpression of RamA lead to decreased porin production and increased expression of efflux pump components, whereas overexpression of RamR had the opposite effects. CONCLUSION: Mutations or deletions in ramR, leading to the overexpression of RamA predominated in clinical MDR E. aerogenes isolates and were associated with a higher-level of expression of efflux pump components. It was hypothesised that mutations in ramR, and the self-regulating region proximal to ramA, probably altered the binding properties of the RamR repressor; thereby producing the MDR phenotype. Consequently, mutability of RamR may play a key role in predisposing E. aerogenes towards the emergence of a MDR phenotype.


Subject(s)
Drug Resistance, Multiple, Bacterial/genetics , Enterobacter aerogenes/drug effects , Enterobacter aerogenes/genetics , Gene Expression Regulation, Bacterial , Multidrug Resistance-Associated Proteins/genetics , Transcription Factors/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Enterobacteriaceae Infections/microbiology , Genes, araC , Genetic Loci , Humans , Microbial Sensitivity Tests , Multidrug Resistance-Associated Proteins/metabolism , Mutation , Porins/biosynthesis , Porins/genetics , Transcription Factors/metabolism
5.
PLoS One ; 12(11): e0188936, 2017.
Article in English | MEDLINE | ID: mdl-29190673

ABSTRACT

BACKGROUND: Water serves as a potential reservoir for Campylobacter, the leading cause of bacterial gastroenteritis in humans. However, little is understood about the mechanisms underlying variations in survival characteristics between different strains of C. jejuni in natural environments, including water. RESULTS: We identified three Campylobacter jejuni strains that exhibited variability in their ability to retain culturability after suspension in tap water at two different temperatures (4°C and 25°C). Of the three, strains C. jejuni M1 exhibited the most rapid loss of culturability whilst retaining viability. Using RNAseq transcriptomics, we characterised C. jejuni M1 gene expression in response to suspension in water by analyzing bacterial suspensions recovered immediately after introduction into water (Time 0), and from two sampling time/temperature combinations where considerable loss of culturability was evident, namely (i) after 24 h at 25°C, and (ii) after 72 h at 4°C. Transcript data were compared with a culture-grown control. Some gene expression characteristics were shared amongst the three populations recovered from water, with more genes being up-regulated than down. Many of the up-regulated genes were identified in the Time 0 sample, whereas the majority of down-regulated genes occurred in the 25°C (24 h) sample. CONCLUSIONS: Variations in expression were found amongst genes associated with oxygen tolerance, starvation and osmotic stress. However, we also found upregulation of flagellar assembly genes, accompanied by down-regulation of genes involved in chemotaxis. Our data also suggested a switch from secretion via the sec system to via the tat system, and that the quorum sensing gene luxS may be implicated in the survival of strain M1 in water. Variations in gene expression also occurred in accessory genome regions. Our data suggest that despite the loss of culturability, C. jejuni M1 remains viable and adapts via specific changes in gene expression.


Subject(s)
Campylobacter jejuni/genetics , Genes, Bacterial , Transcriptome , Campylobacter jejuni/pathogenicity , Campylobacter jejuni/physiology , Electron Transport , Gene Expression Regulation, Bacterial , Osmotic Pressure , Oxidative Stress , Quorum Sensing , Sequence Analysis, RNA , Temperature , Virulence/genetics , Water Microbiology
6.
BMC Microbiol ; 17(1): 3, 2017 01 05.
Article in English | MEDLINE | ID: mdl-28056789

ABSTRACT

BACKGROUND: During chronic lung infections of cystic fibrosis patients Pseudomonas aeruginosa populations undergo extensive evolutionary diversification. However, the selective drivers of this evolutionary process are poorly understood. To test the effects of temperate phages on diversification in P. aeruginosa biofilms we experimentally evolved populations of P. aeruginosa for approximately 240 generations in artificial sputum medium with or without a community of three temperate phages. RESULTS: Analysis of end-point populations using a suite of phenotypic tests revealed extensive phenotypic diversification within populations, but no significant differences between the populations evolved with or without phages. The most common phenotypic variant observed was loss of all three types of motility (swimming, swarming and twitching) and resistance to all three phages. Despite the absence of selective pressure, some members of the population evolved antibiotic resistance. The frequency of antibiotic resistant isolates varied according to population and the antibiotic tested. However, resistance to ceftazidime and tazobactam-piperacillin was observed more frequently than resistance to other antibiotics, and was associated with higher prevelence of isolates exhibiting a hypermutable phenotype and increased beta-lactamase production. CONCLUSIONS: We observed considerable within-population phenotypic diversity in P. aeruginosa populations evolving in the artificial sputum medium biofilm model. Replicate populations evolved both in the presence and absence of phages converged upon similar sets of phenotypes. The evolved phenotypes, including antimicrobial resistance, were similar to those observed amongst clinical isolates from cystic fibrosis infections.


Subject(s)
Biodiversity , Biological Evolution , Phenotype , Pseudomonas aeruginosa/physiology , Sputum/microbiology , Bacteriophages , Biofilms/growth & development , Culture Media/chemistry , Cystic Fibrosis/microbiology , Drug Resistance, Microbial , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/pharmacology , Piperacillin/pharmacology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/virology , Sputum/chemistry , Tazobactam , beta-Lactamases/metabolism
7.
Proc Natl Acad Sci U S A ; 113(29): 8266-71, 2016 07 19.
Article in English | MEDLINE | ID: mdl-27382184

ABSTRACT

Temperate phages drive genomic diversification in bacterial pathogens. Phage-derived sequences are more common in pathogenic than nonpathogenic taxa and are associated with changes in pathogen virulence. High abundance and mobilization of temperate phages within hosts suggests that temperate phages could promote within-host evolution of bacterial pathogens. However, their role in pathogen evolution has not been experimentally tested. We experimentally evolved replicate populations of Pseudomonas aeruginosa with or without a community of three temperate phages active in cystic fibrosis (CF) lung infections, including the transposable phage, ɸ4, which is closely related to phage D3112. Populations grew as free-floating biofilms in artificial sputum medium, mimicking sputum of CF lungs where P. aeruginosa is an important pathogen and undergoes evolutionary adaptation and diversification during chronic infection. Although bacterial populations adapted to the biofilm environment in both treatments, population genomic analysis revealed that phages altered both the trajectory and mode of evolution. Populations evolving with phages exhibited a greater degree of parallel evolution and faster selective sweeps than populations without phages. Phage ɸ4 integrated randomly into the bacterial chromosome, but integrations into motility-associated genes and regulators of quorum sensing systems essential for virulence were selected in parallel, strongly suggesting that these insertional inactivation mutations were adaptive. Temperate phages, and in particular transposable phages, are therefore likely to facilitate adaptive evolution of bacterial pathogens within hosts.


Subject(s)
Bacteriophages/genetics , Pseudomonas aeruginosa/genetics , Adaptation, Physiological , Biofilms , Biological Evolution , Mutation , Pseudomonas aeruginosa/growth & development , Sputum/microbiology
8.
ISME J ; 10(10): 2553-5, 2016 10.
Article in English | MEDLINE | ID: mdl-27070941

ABSTRACT

The Liverpool Epidemic Strain (LES) is a polylysogenic, transmissible strain of Pseudomonas aeruginosa, capable of superinfecting existing P. aeruginosa respiratory infections in individuals with cystic fibrosis (CF). The LES phages are highly active in the CF lung and may have a role in the competitiveness of the LES in vivo. In this study, we tested this by competing isogenic PAO1 strains that differed only by the presence or absence of LES prophages in a rat model of chronic lung infection. Lysogens invaded phage-susceptible populations, both in head-to-head competition and when invading from rare, in the spatially structured, heterogeneous lung environment. Appreciable densities of free phages in lung tissue confirmed active phage lysis in vivo. Moreover, we observed lysogenic conversion of the phage-susceptible competitor. These results suggest that temperate phages may have an important role in the competitiveness of the LES in chronic lung infection by acting as anti-competitor weapons.


Subject(s)
Bacteriophages/physiology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/physiology , Respiratory Tract Infections/microbiology , Animals , Chronic Disease , Humans , Lung/microbiology , Lung/virology , Lysogeny , Rats
9.
FEMS Microbiol Lett ; 363(5): fnw015, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26825679

ABSTRACT

Bacteriophages are viruses that infect bacteria. There are an estimated 10(31) phage on the planet, making them the most abundant form of life. We are rapidly approaching the centenary of their identification, and yet still have only a limited understanding of their role in the ecology and evolution of bacterial populations. Temperate prophage carriage is often associated with increased bacterial virulence. The rise in use of technologies, such as genome sequencing and transcriptomics, has highlighted more subtle ways in which prophages contribute to pathogenicity. This review discusses the current knowledge of the multifaceted effects that phage can exert on their hosts and how this may contribute to bacterial adaptation during infection.


Subject(s)
Bacteria/pathogenicity , Bacteria/virology , Bacteriophages/genetics , Exotoxins/genetics , Lysogeny/genetics , Bacteria/genetics , Bacterial Infections/genetics , Bacterial Infections/microbiology , Life Cycle Stages/genetics , Prophages/genetics , Virulence Factors/genetics
10.
Evol Appl ; 8(4): 346-51, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25926879

ABSTRACT

The rise of next generation sequencing is revealing a hidden diversity of temperate phages within the microbial community. While a handful of these phages have been well characterized, for the vast majority, the role of phage carriage, and especially multiple phage carriage, is poorly understood. The Liverpool epidemic strain of Pseudomonas aeruginosa is an aggressive pathogen in cystic fibrosis lung infections that has recently been found to contain several unique prophages within its genome. Here, we experimentally investigate the role of two of these phages in vivo, using an insect model of infection. We find that while no benefit is conferred by phage carriage in single bacterial infections, phages confer a large fitness advantage during mixed infections by mediating bacteria-bacteria competition. Differences between the two phages appeared to be associated with the rate at which the competitor acquired the phage, and therefore resistance. However, the advantage was greatest in the polylysogen, carrying both phages. These findings suggest that the LES phages may play an important role in host invasions and more generally show that the carriage of multiple phages may itself be beneficial by hindering the spread of resistance in rival bacterial populations.

11.
ISME J ; 9(6): 1391-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25461970

ABSTRACT

Pseudomonas aeruginosa is the most common bacterial pathogen infecting the lungs of cystic fibrosis (CF) patients. The transmissible Liverpool epidemic strain (LES) harbours multiple inducible prophages (LESϕ2; LESϕ3; LESϕ4; LESϕ5; and LESϕ6), some of which are known to confer a competitive advantage in an in vivo rat model of chronic lung infection. We used quantitative PCR (Q-PCR) to measure the density and dynamics of all five LES phages in the sputa of 10 LES-infected CF patients over a period of 2 years. In all patients, the densities of free-LES phages were positively correlated with the densities of P. aeruginosa, and total free-phage densities consistently exceeded bacterial host densities 10-100-fold. Further, we observed a negative correlation between the phage-to-bacterium ratio and bacterial density, suggesting a role for lysis by temperate phages in regulation of the bacterial population densities. In 9/10 patients, LESϕ2 and LESϕ4 were the most abundant free phages, which reflects the differential in vitro induction properties of the phages. These data indicate that temperate phages of P. aeruginosa retain lytic activity after prolonged periods of chronic infection in the CF lung, and suggest that temperate phage lysis may contribute to regulation of P. aeruginosa density in vivo.


Subject(s)
Cystic Fibrosis/microbiology , Pseudomonas Infections/microbiology , Pseudomonas Phages/physiology , Pseudomonas aeruginosa/virology , Respiratory Tract Infections/microbiology , Animals , Complement System Proteins , Disease Models, Animal , Humans , Lung/microbiology , Polymerase Chain Reaction , Prophages , Sputum/microbiology
12.
FEMS Microbiol Lett ; 356(1): 8-19, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24888326

ABSTRACT

Campylobacter species are the most common cause of bacterial gastroenteritis, with C. jejuni responsible for the majority of these cases. Although it is clear that livestock, and particularly poultry, are the most common source, it is likely that the natural environment (soil and water) plays a key role in transmission, either directly to humans or indirectly via farm animals. It has been shown using multilocus sequence typing that some clonal complexes (such as ST-45) are more frequently isolated from environmental sources such as water, suggesting that strains vary in their ability to survive in the environment. Although C. jejuni are fastidious microaerophiles generally unable to grow in atmospheric levels of oxygen, C. jejuni can adapt to survival in the environment, exhibiting aerotolerance and starvation survival. Biofilm formation, the viable but nonculturable state, and interactions with other microorganisms can all contribute to survival outside the host. By exploiting high-throughput technologies such as genome sequencing and RNA Seq, we are well placed to decipher the mechanisms underlying the variations in survival between strains in environments such as soil and water and to better understand the role of environmental persistence in the transmission of C. jejuni directly or indirectly to humans.


Subject(s)
Biofilms , Campylobacter Infections/transmission , Campylobacter jejuni/physiology , Environmental Microbiology , Gastroenteritis/microbiology , Animals , Campylobacter Infections/microbiology , Genes, Bacterial , Humans , Microbial Interactions , Microbial Viability
13.
BMC Microbiol ; 12: 216, 2012 09 21.
Article in English | MEDLINE | ID: mdl-22998633

ABSTRACT

BACKGROUND: Pseudomonas aeruginosa is the most common bacterial pathogen infecting the lungs of patients with cystic fibrosis (CF). The Liverpool Epidemic Strain (LES) is transmissible, capable of superseding other P. aeruginosa populations and is associated with increased morbidity. Previously, multiple inducible prophages have been found to coexist in the LES chromosome and to constitute a major component of the accessory genome not found in other sequenced P. aerugionosa strains. LES phages confer a competitive advantage in a rat model of chronic lung infection and may, therefore underpin LES prevalence. Here the infective properties of three LES phages were characterised. RESULTS: This study focuses on three of the five active prophages (LESφ2, LESφ3 and LESφ4) that are members of the Siphoviridae. All were induced from LESB58 by norfloxacin. Lytic production of LESφ2 was considerably higher than that of LESφ3 and LESφ4. Each phage was capable of both lytic and lysogenic infection of the susceptible P. aeruginosa host, PAO1, producing phage-specific plaque morphologies. In the PAO1 host background, the LESφ2 prophage conferred immunity against LESφ3 infection and reduced susceptibility to LESφ4 infection. Each prophage was less stable in the PAO1 chromosome with substantially higher rates of spontaneous phage production than when residing in the native LESB58 host. We show that LES phages are capable of horizontal gene transfer by infecting P. aeruginosa strains from different sources and that type IV pili are required for infection by all three phages. CONCLUSIONS: Multiple inducible prophages with diverse infection properties have been maintained in the LES genome. Our data suggest that LESφ2 is more sensitive to induction into the lytic cycle or has a more efficient replicative cycle than the other LES phages.


Subject(s)
Prophages/growth & development , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/virology , Adult , Animals , Anti-Bacterial Agents/metabolism , Child , Child, Preschool , Cystic Fibrosis/complications , Fimbriae, Bacterial/physiology , Humans , Lysogeny , Norfloxacin/metabolism , Prophages/isolation & purification , Prophages/physiology , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , Siphoviridae/growth & development , Siphoviridae/isolation & purification , Siphoviridae/physiology , Transduction, Genetic , Viral Plaque Assay , Virus Activation/drug effects , Virus Internalization
14.
J Vis Exp ; (64): e3857, 2012 Jun 05.
Article in English | MEDLINE | ID: mdl-22711026

ABSTRACT

There is growing concern about the relevance of in vitro antimicrobial susceptibility tests when applied to isolates of P. aeruginosa from cystic fibrosis (CF) patients. Existing methods rely on single or a few isolates grown aerobically and planktonically. Predetermined cut-offs are used to define whether the bacteria are sensitive or resistant to any given antibiotic. However, during chronic lung infections in CF, P. aeruginosa populations exist in biofilms and there is evidence that the environment is largely microaerophilic. The stark difference in conditions between bacteria in the lung and those during diagnostic testing has called into question the reliability and even relevance of these tests. Artificial sputum medium (ASM) is a culture medium containing the components of CF patient sputum, including amino acids, mucin and free DNA. P. aeruginosa growth in ASM mimics growth during CF infections, with the formation of self-aggregating biofilm structures and population divergence. The aim of this study was to develop a microtitre-plate assay to study antimicrobial susceptibility of P. aeruginosa based on growth in ASM, which is applicable to both microaerophilic and aerobic conditions. An ASM assay was developed in a microtitre plate format. P. aeruginosa biofilms were allowed to develop for 3 days prior to incubation with antimicrobial agents at different concentrations for 24 hours. After biofilm disruption, cell viability was measured by staining with resazurin. This assay was used to ascertain the sessile cell minimum inhibitory concentration (SMIC) of tobramycin for 15 different P. aeruginosa isolates under aerobic and microaerophilic conditions and SMIC values were compared to those obtained with standard broth growth. Whilst there was some evidence for increased MIC values for isolates grown in ASM when compared to their planktonic counterparts, the biggest differences were found with bacteria tested in microaerophilic conditions, which showed a much increased resistance up to a > 128 fold, towards tobramycin in the ASM system when compared to assays carried out in aerobic conditions. The lack of association between current susceptibility testing methods and clinical outcome has questioned the validity of current methods. Several in vitro models have been used previously to study P. aeruginosa biofilms. However, these methods rely on surface attached biofilms, whereas the ASM biofilms resemble those observed in the CF lung. In addition, reduced oxygen concentration in the mucus has been shown to alter the behavior of P. aeruginosa and affect antibiotic susceptibility. Therefore using ASM under microaerophilic conditions may provide a more realistic environment in which to study antimicrobial susceptibility.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cystic Fibrosis/microbiology , Lung/microbiology , Microbial Sensitivity Tests/methods , Pseudomonas aeruginosa/drug effects , Sputum/microbiology , Biofilms/drug effects , Humans , Oxazines/analysis , Oxazines/metabolism , Pseudomonas aeruginosa/metabolism , Pseudomonas aeruginosa/physiology , Sputum/chemistry , Tobramycin/pharmacology , Xanthenes/analysis , Xanthenes/metabolism
15.
Expert Rev Anti Infect Ther ; 10(2): 219-35, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22339195

ABSTRACT

Pseudomonas aeruginosa is a highly successful opportunistic pathogen that displays intrinsic multidrug resistance and has a tremendous capacity to acquire further resistance mechanisms. During chronic infection, the bacterium can form a protective biofilm therefore reducing the efficacy of existing antibiotics. P. aeruginosa also harbors an impressive range of virulence factors, many of which are controlled by the quorum-sensing system. Several novel therapeutics are under investigation such as those directed against biofilm formation and quorum-sensing systems along with bacteriophages and immunotherapies. Recent advances in next-generation sequencing and comparative genomics have opened the door to a new wave of smart drug design that could revolutionize P. aeruginosa treatment options.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Pseudomonas Infections/therapy , Pseudomonas aeruginosa/drug effects , Quorum Sensing/drug effects , Anti-Bacterial Agents/administration & dosage , Bacterial Adhesion/drug effects , Bacteriocins/administration & dosage , Bacteriocins/therapeutic use , Biofilms/drug effects , Biofilms/growth & development , Drug Resistance, Multiple, Bacterial , Humans , Immunotherapy , Iron Chelating Agents/administration & dosage , Iron Chelating Agents/therapeutic use , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Pseudomonas Infections/immunology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/genetics , Quorum Sensing/genetics , Virulence/drug effects , Virulence/genetics
16.
Antimicrob Agents Chemother ; 55(1): 426-8, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20974862

ABSTRACT

Phage production in response to antibiotics varied among four isolates of a Pseudomonas aeruginosa cystic fibrosis (CF) epidemic strain. Whereas ciprofloxacin induced higher levels of phage production, other CF-relevant antibiotics led to reduced production. We detected free phages directly in CF patient sputum samples by both plaque (40% positive) and PCR (76% positive) assays. Our observations suggest that the choice of antibiotics could influence the number of free phages within the CF lung environment.


Subject(s)
Bacteriophages/drug effects , Cystic Fibrosis/microbiology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/virology , Bacteriophages/genetics , Humans , Polymerase Chain Reaction , Pseudomonas aeruginosa/pathogenicity
17.
Pharmacogenet Genomics ; 20(2): 112-20, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20051929

ABSTRACT

OBJECTIVE: OATP1B1 and OATP1B3 are major hepatic drug transporters whilst OATP1A2 is mainly located in the brain but is also located in liver and several other organs. These transporters affect the distribution and clearance of many endobiotics and xenobiotics and have been reported to have functional single nucleotide polymorphisms (SNPs). We have assessed the substrate specificities of these transporters for a panel of antiretrovirals and investigated the effects of SNPs within these transporters on the pharmacokinetics of lopinavir. METHODS: SLCO1A2, SLCO1B1 and SLCO1B3 were cloned, verified and used to generate cRNA for use in the Xenopuslaevis oocyte transport system. Using the oocyte system, antiretrovirals were tested for their substrate specificities. Plasma samples (n=349) from the Liverpool therapeutic drug monitoring registry were genotyped for SNPs in SLCO1A2, SLCO1B1 and SLCO1B3 and associations between SNPs and lopinavir plasma concentrations were analysed. RESULT: Antiretroviral protease inhibitors, but not non-nucleoside reverse transcriptase inhibitors, are substrates for OATP1A2, OATP1B1 and OATP1B3. Furthermore, ritonavir was not an inhibitor of OATP1B1. The 521T>C polymorphism in SLCO1B1 was significantly associated with higher lopinavir plasma concentrations. No associations were observed with functional variants of SLCO1A2 and SLCO1B3. CONCLUSION: These data add to our understanding of the factors that contribute to variability in plasma concentrations of protease inhibitors. Further studies are now required to confirm the association of SLCO1B1 521T>C with lopinavir plasma concentrations and to assess the influence of other polymorphisms in the SLCO family.


Subject(s)
HIV Protease Inhibitors/metabolism , Organic Anion Transporters, Sodium-Independent/metabolism , Organic Anion Transporters/genetics , Organic Anion Transporters/metabolism , Polymorphism, Genetic , Pyrimidinones/blood , Adult , Animals , Biological Transport/drug effects , Cloning, Molecular , Drug Monitoring , Estrone/analogs & derivatives , Estrone/metabolism , Female , Gene Expression Regulation/drug effects , Genotype , HIV Protease Inhibitors/pharmacology , Humans , Liver-Specific Organic Anion Transporter 1 , Lopinavir , Male , Middle Aged , Organic Anion Transporters, Sodium-Independent/genetics , Polymorphism, Genetic/drug effects , Pyrimidinones/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Registries , Ritonavir/pharmacology , Solute Carrier Organic Anion Transporter Family Member 1B3 , Substrate Specificity/drug effects , Xenopus , Young Adult
18.
PLoS One ; 4(5): e5453, 2009.
Article in English | MEDLINE | ID: mdl-19434239

ABSTRACT

BACKGROUND: Multi-drug resistant (MDR) infections have become a major concern in hospitals worldwide. This study investigates membrane translocation, which is the first step required for drug action on internal bacterial targets. beta-lactams, a major antibiotic class, use porins to pass through the outer membrane barrier of Gram-negative bacteria. Clinical reports have linked the MDR phenotype to altered membrane permeability including porin modification and efflux pump expression. METHODOLOGY/PRINCIPAL FINDINGS: Here influx of beta-lactams through the major Enterobacter aerogenes porin Omp36 is characterized. Conductance measurements through a single Omp36 trimer reconstituted into a planar lipid bilayer allowed us to count the passage of single beta-lactam molecules. Statistical analysis of each transport event yielded the kinetic parameters of antibiotic travel through Omp36 and distinguishable translocation properties of beta-lactams were quantified for ertapenem and cefepime. Expression of Omp36 in an otherwise porin-null bacterial strain is shown to confer increases in the killing rate of these antibiotics and in the corresponding bacterial susceptibility. CONCLUSIONS/SIGNIFICANCE: We propose the idea of a molecular "passport" that allows rapid transport of substrates through porins. Deciphering antibiotic translocation provides new insights for the design of novel drugs that may be highly effective at passing through the porin constriction zone. Such data may hold the key for the next generation of antibiotics capable of rapid intracellular accumulation to circumvent the further development MDR infections.


Subject(s)
Anti-Bacterial Agents/metabolism , Escherichia coli/metabolism , Porins/metabolism , beta-Lactams/metabolism , Anti-Bacterial Agents/pharmacology , Biological Transport/drug effects , Escherichia coli/drug effects , Escherichia coli Proteins/metabolism , Kinetics , Lipid Bilayers/metabolism , beta-Lactams/pharmacology
19.
Nat Rev Microbiol ; 6(12): 893-903, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18997824

ABSTRACT

Gram-negative bacteria are responsible for a large proportion of antibiotic-resistant bacterial diseases. These bacteria have a complex cell envelope that comprises an outer membrane and an inner membrane that delimit the periplasm. The outer membrane contains various protein channels, called porins, which are involved in the influx of various compounds, including several classes of antibiotics. Bacterial adaptation to reduce influx through porins is an increasing problem worldwide that contributes, together with efflux systems, to the emergence and dissemination of antibiotic resistance. An exciting challenge is to decipher the genetic and molecular basis of membrane impermeability as a bacterial resistance mechanism. This Review outlines the bacterial response towards antibiotic stress on altered membrane permeability and discusses recent advances in molecular approaches that are improving our knowledge of the physico-chemical parameters that govern the translocation of antibiotics through porin channels.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/pharmacokinetics , Bacterial Proteins/physiology , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/physiology , Porins/physiology , Animals , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Cell Membrane Permeability/drug effects , Diffusion , Drug Resistance, Bacterial/physiology , Gram-Negative Bacteria/genetics , Gram-Negative Bacteria/pathogenicity , Humans , Models, Biological , Models, Molecular , Mutation , Porins/chemistry , Porins/genetics
20.
Curr Drug Targets ; 9(9): 750-9, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18781921

ABSTRACT

In Enterobacteriaceae, membrane permeability is a key in the level of susceptibility to antibiotics. Modification of the bacterial envelope by decreasing the porin production or increasing the expression of efflux pump systems has been reported. These phenomena are frequently associated with other resistance mechanisms such as alteration of antibiotics or modification of the drug targets, in various clinical isolates showing a Multi Drug Resistant phenotype (MDR). In Escherichia coli, Enterobacter aerogenes, Klebsiella pneumoniae and Salmonella enterica several genes and external factors are involved in the emergence of MDR isolates. These bacterial isolates exhibit a noticeable reduction of functional porins per cell due to a decrease, a complete shutdown of synthesis, or the expression of an altered porin and a high expression of efflux systems (e.g. overexpression of the pump). The combined action of these mechanisms during an infection confers a significant decrease in bacterial sensitivity to antibiotherapy ensuring dissemination and colonization of the patient and favours the acquisition of additional mechanisms of resistance. MarA and ramA are involved in a complex regulation cascade controlling membrane permeability and actively participate in the triggering of the MDR phenotype. Mutations in regulator genes have been shown to induce the overproduction of efflux and the down-regulation of porin synthesis. In addition, various compounds such as salicylate, imipenem or chloramphenicol are able to activate the MDR response. This phenomenon has been observed both in vitro during culture of bacteria in the presence of drugs and in vivo during antibiotic treatment of infected patients. These effectors activate the expression of specific global regulators, marA, ramA, or target other genes located downstream in the regulation cascade.


Subject(s)
Anti-Bacterial Agents/metabolism , Cell Membrane Permeability/physiology , Enterobacteriaceae/metabolism , Biological Transport/genetics , Drug Resistance, Multiple, Bacterial/drug effects , Drug Resistance, Multiple, Bacterial/genetics , Enterobacteriaceae/genetics , Enterobacteriaceae Infections/drug therapy , Gene Expression Regulation, Bacterial , Humans , Porins/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...